MyDawa, a Kenyan end-to-end digital health platform, has raised funding to reimagine how healthcare is accessed and experienced in Africa.
This investment round was led by IFU, Alta Semper, AAIC Investment, Creadev and Ohara Pharmaceutical Co. to help the firm redefine how healthcare is delivered across the continent.
“The calibre of investors joining this round speaks for itself,” said Neil O’Leary, MyDawa Founder. “It confirms that MyDawa is not just solving real problems at scale—it’s building a blueprint for the future of healthcare in Africa. We’re honoured to have partners who share our vision and will help us accelerate our mission.”
Across East Africa, strides in digital healthcare are opening up new possibilities – yet many communities still face delays, uneven availability, and price fluctuations when sourcing essential medicines. This funding by globally recognised healthcare investors will help address these barriers using cutting-edge technology.
Founded in 2017, MyDawa offers online doctor consultations, lab testing, e-prescriptions, chronic-care management and medication delivery in Kenya and Uganda where it launched in 2023 after raising $20 million and acquiring Uganda’s Guardian Health pharmacy chain in an international expansion drive.
Driving Technology, Reach and Impact
This capital infusion will enable MyDawa to scale its “Bricks-and-Clicks Super Pharmacy” model across new markets, enhance chronic-disease support programmes for patients who need regular, affordable care, and integrate AI-driven features to streamline service delivery, optimise inventory management, and ultimately reduce costs for patients.
“As MyDawa’s long-term partner, we’ve witnessed firsthand the company’s ability to deliver transformative healthcare solutions at scale,” added Zach Fond, Partner at Alta Semper. “We’re excited to see this next phase of growth, which reinforces MyDawa’s position as a category leader and a blueprint for digital health innovation across Africa.”
Recently, MyDawaA acquired Rocket Health Uganda, a leading telehealth provider, significantly expanding its footprint and capabilities in Uganda. This investment will further drive regional expansion and widescale upgrades to the platform.
In 2024 alone, MyDawa served over 1.8 million patients and enrolled more than 5,000 chronic-disease patients in its care programmes. Its “Mzima” programme in Kenya and “Bulunji” programme in Uganda exemplify the company’s commitment to comprehensive, accessible healthcare solutions. Meanwhile, its PrEP and PEP initiatives—funded by the Gates Foundation—support some 3,200 patients in prevention and early treatment. Strategic partnerships with hospitals, clinics, insurers, supermarkets, and pharmaceutical companies such as Novo Nordisk further amplify MyDawa’s reach and impact.
A Blueprint for Sustainable Growth
With a low customer-acquisition cost and year-on-year revenue growth exceeding 30%, MyDawa exemplifies both scale and sustainability in digital health. Its strategic alliances with hospitals, insurers and global pharmaceutical partners have cemented its leadership in the digital health space.
“This investment marks a pivotal step towards realising MyDawa’s vision of a digitally empowered, accessible and customer-centric healthcare ecosystem for every East African. Through this investment, we are positioned to deliver on the vision faster and more effectively than ever,” concludes MyDawa COO, Priscilla Muhiu.
Reading This Now 503
